Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The packaging solutions manufacturer has expanded its ESOP, giving employees full ownership of the company.
September 22, 2026
By: Charlie Sternberg
James Alexander Corporation (JAC), a manufacturer of innovative dispensing and packaging solutions, has transitioned to 100% employee ownership through its Employee Stock Ownership Plan (ESOP), effective immediately.
The transaction represents a natural evolution of a commitment to employees that began in 2011, when JAC founder and Chairwoman Francesca Fazzolari established the company’s ESOP, giving employees a 20% ownership stake.
“Fifty years ago, James Alexander was founded with a vision for creating something special,” said Fazzolari. “As we celebrate 50 years, I can think of no better way to begin the company’s next chapter than by putting its future entirely in the hands of the people who have helped build it.”
“Since we established the ESOP in 2011, I have watched our employees embrace the responsibility and opportunity that comes with ownership. Today, they are not simply part owners – they are the owners. I couldn’t be more proud of them or more confident in the future of James Alexander.”
When JAC became an ESOP company, Fazzolari described the decision as a way to provide employees with something greater than a traditional bonus and to create an additional retirement benefit. As the company grows, employees benefit from the value they help create.
Many JAC employees have dedicated decades to the company, with some employees having been part of the organization for more than 20 years. The transition to 100% employee ownership recognizes that history while giving employees an even greater stake in the company’s continued success.
“Reaching 50 years is an extraordinary achievement,” said Fazzolari. “But this isn’t about looking back. It’s about looking forward. The next 50 years belong to our employees, and I am excited to see what they will accomplish.”
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !